About Vanderbilt Vaccine (VV) CRS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Vanderbilt Vaccine (VV) CRS
During the past decade, Vanderbilt Vaccine (VV) CRS conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt Vaccine (VV) CRS"
#1 collaborator was "HIV Vaccine Trials Network" with 4 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Novartis Vaccines and Diagnostics, Inc" with 1 trials as a collaborator and "Sanofi Pasteur, a Sanofi Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Vanderbilt Vaccine (VV) CRS
According to Clinical.Site data, the most researched conditions in "Vanderbilt Vaccine (VV) CRS" are
"HIV Infections" (18 trials). Many other conditions were trialed in "Vanderbilt Vaccine (VV) CRS" in a lesser frequency.
Clinical Trials Intervention Types at Vanderbilt Vaccine (VV) CRS
Most popular intervention types in "Vanderbilt Vaccine (VV) CRS" are "Biological" (17 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "10-1074" (1 trials), "AIDSVAX B/E Vaccine" (1 trials), "ALVAC-HIV (vCP2438)" (1 trials) and "Bivalent Subtype C gp120/AS01B vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Vanderbilt Vaccine (VV) CRS
The vast majority of trials in "Vanderbilt Vaccine (VV) CRS" are
16 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Vanderbilt Vaccine (VV) CRS
Currently, there are NaN active trials in "Vanderbilt Vaccine (VV) CRS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Vanderbilt Vaccine (VV) CRS,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Vanderbilt Vaccine (VV) CRS, 14 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".